NeuroDex
Tracked across 1 events · 6 articles · First seen Jul 01, 2026 · Last active Jul 01, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: NeuroDex announced new findings supporting its ExoSORT platform for measuring TDP-43 as a treatment-responsive biomarker in ALS, which could significantly advance its diagnostic capabilities and market position.
Jul 01, 2026 · 6 articles
100
NeuroDex announced findingsNeuroDex ExoSORT ALS...
70
NeuroDex applied workflow NeuroSense TherapeuticsNeuroDex ExoSORT ALS...
ERGEN INTELLIGENCE
Track NeuroDex live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard